| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 514552000 | Z contains an unbroken chain of at least seven carbon atoms bonded directly to the C(=O) group | 60 |
| 20080214665 | Novel Approach to Anti-Microbial Host Defense with Molecular Shields with Lipoxin Compounds - Methods to cause tissue, such as mucosal cells, to express increased amounts of bactericidal permeability increasing protein (BPI) are described. The BPI inducing agents include, for example, lipoxin compounds. | 09-04-2008 |
| 20080249172 | Cosmetic Oil Substances - A storage-stable, smooth-feeling, non-comedogenic fatty acid ester mixture of 2-ethylhexanol and fatty acids comprising 2-ethylhexyl fatty acid esters, wherein the aggregate amount of C | 10-09-2008 |
| 20080262084 | Stable Emulsion Compositions for Intravenous Administration Having Preservatie Efficacy - Monoglycerides, especially Monolaurin, are used to protect intravenously administrable oil-in-water emulsion compositions against growth of | 10-23-2008 |
| 20080287537 | Composition, Particularly a Cosmetic Composition, Comprising ((Dialkylamino)Alkoxy) Ethanol Ester - The present invention relates to a process for the cosmetic treatment of wrinkled skin, comprising the topical application to the said skin of a composition comprising, in a physiologically acceptable medium, at least one ester of ((dialkylamino)alkoxy)ethanol of formula (I): | 11-20-2008 |
| 20080287538 | Antimicrobial Compositions and Methods - Antimicrobial compositions, especially those useful when applied topically, particularly to mucosal tissues (i.e., mucous membranes), including, in particular, a fatty alcohol ester of a hydroxycarboxylic acid, alkoxylated derivatives thereof, or combinations thereof. The compositions can also include an enhancer component, a surfactant component, a hydrophobic component, and/or a hydrophilic component. Such compositions provide effective topical antimicrobial activity and are accordingly useful in the treatment and/or prevention of conditions that are caused, or aggravated by, microorganisms (including viruses). | 11-20-2008 |
| 20090005448 | Injection for Mastitis - Disclosed is infusion for mastitis which contains a main ingredient, medium-chain fatty acid monoglyceride and an oily base wherein diffusivity and dispersivity of the main ingredient are improved by the monoglyceride to enhance dissolubility and thus absorbency of the main ingredient. In comparison with conventional infusions for mastitis, the infusion has immediate effectivity and is short in residual term; the main ingredient is expected to be utilized effectively and without waste. | 01-01-2009 |
| 20090018193 | ESSENTIAL FATTY ACIDS IN THE PREVENTION OF CARDIOVASCULAR EVENTS - The invention concerns the use of essential fatty acids with a high content in eicosapentaenoic acid ethyl ester (EPA) or docosahexaenoic acid ethyl ester (DHA) or a high concentration mixture thereof in the preparation of a medicament useful for preventing mortality, in particular due to sudden death, in patients who have suffered from a myocardial infarction. | 01-15-2009 |
| 20090170942 | ESTER DERIVATIVE AND USE THEREOF - A compound represented by the following formula (I′) | 07-02-2009 |
| 20090170943 | Spider esters in personal care applications - The present invention is drawn to a process for providing emolliency to the skin using a series so called “spider esters”. These esters are derived from poly-hydroxy functional compounds sequentially reacted with ethylene oxide or propylene oxide, followed by the reaction of the alkoxylate with fatty acid. The resulting products are called spider esters because they resemble the spider, wherein appendages are alkoxylated esters. The restrictions this orientation imposes on rotation allows for the preparation of polar esters that have little or no water solubility, and provide both moisturization to the skin and emolliency by reducing transepidermal water loss. | 07-02-2009 |
| 20090197952 | Glyceride Esters for the Treatment of Diseases Associated with Reduced Neuronal Metabolism of Glucose - Provided are alternative sources of ketone bodies for reducing or eliminating symptoms of Parkinson's disease, amyotrophic lateral sclerosis (ALS, also called Lou Gehrig's disease), Alzheimer's disease, Huntington's disease, epilepsy and other diseases or disorders characterized by impaired glucose metabolism. The alternative sources of ketone bodies include mono-, di- and triglyceride esters of acetoacetate and mixtures thereof, and/or mono-, di- and triglyceride esters of 3-hydroxybutyrate and mixtures thereof. These glyceride esters can be administered orally as a dietary supplement or in a nutritional composition. | 08-06-2009 |
| 20090215892 | Octanol Formulations and Methods of Treatment Using the Same - The invention features pharmaceutical formulations containing octanol and esters thereof. The pharmaceutical formulations are useful for the treatment of involuntary tremors. | 08-27-2009 |
| 20090318554 | COSMETIC PARTICLES THAT TRANSFORM FROM HARD TO SOFT PARTICLES COMPRISING HYDROGENATED LONG-CHAIN TRIGLYCERIDE OILS - Cosmetic particle compositions are provided which are adapted to form hard cosmetic particles that transform to soft cosmetic particles after their incorporation into topical formulations, particularly surfactant-based topical formulations. The composition includes one or more partially or fully hydrogenated triglyceride oils, at least 50% of which have at least 15% by weight fatty acid moieties with carbon chain lengths of C | 12-24-2009 |
| 20100120911 | PRESERVATIVE SYSTEM FOR COSMETIC FORMULATIONS - Disclosed is a novel method for preserving cosmetic/personal care formulations through a two component preservative system, said system comprising (a) Component I which functions to eliminate the existing microbial contamination load in a natural cosmetic formulation base through an optimized pasteurization method that avoids deep freezing; and (b) Component II that includes the step of adding synergistic blends of fractionated essential oils, extracts and isolated compounds to the pre-pasteurized cosmetic base obtained through the method of component I, wherein the synergistic blends sustain the effects of pasteurization through anti-microbial and anti-oxidant effects, said anti-oxidant effects enhancing further the anti-microbial effects by virtue of inhibiting lipid per oxidation that facilitates the undue proliferation of microbe. | 05-13-2010 |
| 20100120912 | Esters of capsaicinoids as dietary supplements - Provided are nutraceutical or dietary supplemental compositions comprising esterified capsaicinoids. The esterified capsaicinoids may converted to the active parent capsaicinoid compound following enzymatic or chemical hydrolysis. In various embodiments, these esterified capsaicinoids have a higher lipophilicity, lipid solubility and result in less irritation to the stomach than the parent capsaicinoid, and hence may be included in certain dietary supplement formulations, including capsules, pills and tablets dietary supplement formulations. The dietary supplement compositions may be used for pain management in mammals in vivo and/or in the treatment of various pathological conditions in humans. | 05-13-2010 |
| 20100130609 | Ester of Hexyldecanol Having Short-Chained Fatty Acids - The present invention relates to the use of one or more esters of 2-hexyldeconal having fatty acids of the general formula (I) R1-COOH, wherein R1 is a linear or branched, saturated or unsaturated alkyl radical having 1 to 6 carbon atoms, in and/or for the production of cosmetic and/or pharmaceutical preparations. | 05-27-2010 |
| 20100152291 | PRODUCTION METHOD OF CAPSINOID BY DEHYDRATING CONDENSATION, STABILIZING METHOD OF CAPSINOID, AND CAPSINOID COMPOSITION - Capsinoids of formula (3) may be conveniently prepared in a high yield, in a short time, without using a dehydrating agent by esterification of a fatty acid of formula (1) with a hydroxymethylphenol of formula (2) using an enzyme without a solvent or in a low-polar solvent. Addition of a fatty acid represented by formula (4) is effective for stabilizing the ester compound of formula (3). | 06-17-2010 |
| 20100267829 | Pharmaceutical composition comprising low concentrations of environment pollutants - The invention relates to a process for decreasing the amount of environmental pollutants in a mixture comprising a fat or an oil, being edible or for use in cosmetics, the fat or oil containing the environmental pollutants, which process comprises the steps of adding a volatile working fluid to the mixture, where the volatile working fluid comprises at least one of a fatty acid ester, a fatty acid amide, a free fatty acid and a hydro-carbon, and subjecting the mixture with the added volatile working fluid to at least one stripping processing step, in which an amount of environmental pollutant present in the fat or oil, being edible or for use in cosmetics, is separated from the mixture together with the volatile working fluid. The present invention also relates to a volatile environmental pollutants decreasing working fluid, for use in decreasing an amount of environmental pollutants present in a fat or oil, being edible or for use in cosmetics. In addition, the present invention relates to a health supplement, a pharmaceutical and an animal feed product prepared according to the process mentioned above. | 10-21-2010 |
| 20100292328 | Cosmetic Compositions Containing Esters of 2-ethylbutanol - The invention relates to the use of esters of 2-ethylbutanol with C | 11-18-2010 |
| 20100298432 | Cosmetic Compositions Containing Esters of 2-Butyloctanol - The invention relates to the use of esters of 2-butyloctanol with C | 11-25-2010 |
| 20100331411 | FOAMABLE ALCOHOL COMPOSITIONS, SYSTEMS AND METHODS OF USE - A composition, systems for dispensing the composition and methods for the use of the composition are described. The composition comprises:
| 12-30-2010 |
| 20110034556 | USE OF TRANSGLUTAMINASE INHIBITOR IN SKIN TREATMENT - Human skin is treated for cosmetic purposes, in particular for the management of skin irritation and/or inflammation as well as inhibiting ageing effects, which result therefrom by using a topical cream containing at least one transglutaminase inhibitor such as putrescine. | 02-10-2011 |
| 20110065791 | SYSTEM FOR AROMA RELEASE - The invention concerns a process for preparing particles, which particles contain one or more spaces in which a gas phase is present which comprises at least one active ingredient, in particular at least one aroma, flavor or precursor for an aroma or flavor, and which space or spaces are at least substantially surrounded by an enveloping phase which at ambient temperature is at least substantially solid and at least substantially impermeable to the active ingredient, comprising allowing the gaseous active ingredient to migrate from or through the enveloping phase into the space or spaces at a temperature at which the enveloping phase is permeable to the gaseous active ingredient; and then cooling the particles to a temperature at which the enveloping phase of the particles is at least substantially impermeable to the active ingredient in the particles. | 03-17-2011 |
| 20110136906 | USE OF HYDROXYOLEIC ACID AND RELATED COMPOUNDS IN THE MANUFACTURE OF DRUGS - Use of hydroxyoleic acid and its analogous compounds in the manufacture of drugs. Describes the use of hydroxyoleic acid and its analogs of general formula I: COOH—CHR—(CH | 06-09-2011 |
| 20110218245 | USE OF COMPOUNDS TO INHIBIT 5A-REDUCTASE ENZYME ACTIVITY, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM - The object of the present invention is the use of compounds designed to inhibit the activity of the enzyme 5α-reductase. This is a novel use of compounds of general formula (I): | 09-08-2011 |
| 20110224299 | Stabilized Wax Composition and Uses Thereof - Compositions comprising high amounts of low melting point waxes are provided in self-supporting solid or semi-solid form. The low melting point waxes are stabilized in the compositions by the presence of small amounts of higher melting wax. The compositions may provide a cooling sensation when applied to the skin. | 09-15-2011 |
| 20110251277 | FOAMED CLEANSER WITH SUSPENDED PARTICLES - One aspect of the invention is a new foam which includes a liquid having a plurality of bubbles therein and a plurality of particles suspended therein. The foam is made in a dispenser that suspends the bubbles in the liquid. The liquid may be a single liquid with particles therein or may be made from two liquids which are mixed together. The particles may be such that, prior to foaming the particles sink, float or are suspended in the liquid. | 10-13-2011 |
| 20110281946 | POLYMERIC -BASED COMPOSITION - The present invention concerns polymeric-based compositions that are useful in the delivery and sustained release of hydrophobic therapeutic and/or cosmetic agents substantially at the point of injury, infection or, in the case of purely cosmetic applications, the point of treatment. Also provided are methods of preparing such compositions and methods of treatments involving the use of such compositions. | 11-17-2011 |
| 20120029077 | Animal Feed Additive and Animal Feed Comprising Alkyl Esters of Medium Chain Fatty Acids, and their Use in Animal Feed - The invention is directed to an animal feed suitable for feeding mammals, birds and fish, comprising an alkyl ester of a fatty acid, wherein said fatty acid has a chain length of 5-12 carbon atoms, and wherein the dosage of said ester in said animal feed is 50 ppm by weight or higher, based on the total weight of said animal feed. | 02-02-2012 |
| 20120095097 | OPHTHALMIC COMPOSITION - Disclosed is an ophthalmic composition containing (A) not less than 50,000 units/100 mL of vitamin A, (B) not less than 0.4 W/V % of a polyoxyethylene polyoxypropylene glycol, and (C) trometamol. | 04-19-2012 |
| 20120108661 | EMULSIFIED COMPOSITION - The emulsion composition of the present invention contains
| 05-03-2012 |
| 20120115949 | Ester Mixtures And Compositions Comprising Such Ester Mixtures - The present invention is directed to a mixture of esters according to the general formula (I), R | 05-10-2012 |
| 20120149773 | COMPOSITION FOR SKIN IMPROVEMENT COMPRISING HEXAMIDINES AND RETINOIDS - Disclosed is herein a composition comprising hexamidines, derivatives thereof, or pharmaceutically acceptable salts thereof; and retinoids, derivatives thereof, or pharmaceutically acceptable salts thereof, as an active ingredient. The composition of the present invention has effects for preventing, improving or treating acne; controlling sebum; pore-controlling; and preventing, improving or treating skin pigmentation. Also, the composition of the present invention could alleviate skin-irritations caused with retinoids by including ceramides. | 06-14-2012 |
| 20120157525 | TREATING ECZEMA AND/OR PSORIASIS - The treatment of humans or other mammals for eczema and/or psoriasis using dosage forms or compositions that include cetyl myristate alone or (in admixture or serially) both cetyl myristate and cetyl palmitate. | 06-21-2012 |
| 20120172433 | Oil-In-Water Emulsion Skin Care Cosmetic Composition - To provide an oil-in-water emulsion skin care cosmetic composition which, without the addition of a pharmaceutical agent and a film-forming agent or the like thereto, effects an excellent elastic or resilient feeling to skin and is excellent in non-stickiness and stability. An oil-in-water emulsion skin care cosmetic composition, comprising (a) a paraffin wax and/or a polyethylene wax, (b) a microcrystalline wax, and (c) an animal/plant-derived wax which contains, as the main ingredient thereof, an ester of a higher fatty acid having from 20 to 32 carbon atoms and an alcohol having from 28 to 34 carbon atoms, and has a melting point of from 75 to 100° C., in which the ratio of component (a) to component (b) is from 70/30 to 95/5 (by mass). | 07-05-2012 |
| 20120172434 | METHODS FOR IMPROVING TOLERANCE, DIGESTION, AND LIPID SOLUBLE NUTRIENT ABSORPTION IN AN INFANT, TODDLER, OR CHILD - Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component. | 07-05-2012 |
| 20120190743 | COMPOUNDS FOR TREATING DISORDERS OR DISEASES ASSOCIATED WITH NEUROKININ 2 RECEPTOR ACTIVITY - Compounds, pharmaceutical compositions and methods of treating a disorder or disease associated with neurokinin 2 (NK | 07-26-2012 |
| 20120190744 | Preservative System for Cosmetic Formulations- Compositions and Methods Thereof - The present invention relates to preservation of cosmetic formulations. More specifically, the present invention relates to a preservative composition for cosmetic formulations comprising thymol, monolaurin and magnolol obtained from supercritical fluid extracts of | 07-26-2012 |
| 20130046017 | COMPOUNDS PROVIDED WITH ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM - The invention relates to the use of compounds of general formula (I): | 02-21-2013 |
| 20130096194 | ANTIMICROBIAL ARTICLES - The present disclosure describes a method for forming microporous and antimicrobial articles. The method comprises preparing an initial composition containing a semicrystalline polylactic acid material, a nonpolymeric aliphatic ester diluent, and a nucleating agent. The initial composition is heated to form a melt blended composition. Upon cooling, the melt blended composition phase separates into a composition having two continuous phases. A network of interconnected micropores may be formed by stretching the composition, by removing at least a portion of the nonpolymeric aliphatic ester diluent from the composition, or a combination thereof. | 04-18-2013 |
| 20130237600 | TREATING ECZEMA AND/OR PSORIASIS - The treatment of humans or other mammals for eczema and/or psoriasis using dosage forms or compositions that include cetyl myristate alone or (in admixture or serially) both cetyl myristate and cetyl palmitate. | 09-12-2013 |
| 20130281532 | COMPOSITIONS FOR TOPICAL TREATMENT OF MICROBIAL INFECTIONS - The present invention provides compositions and methods for topical treatment of infections. The compositions comprise glycerol monolaurate or a derivative thereof, and are administered topically, for example, to treat viral, fungal or bacterial infections. | 10-24-2013 |
| 20130296426 | ANALGESIC - An object of the present invention is to provide an analgesic effective in a prophylactic or a therapy for various pain diseases. The present invention is to provide an analgesic containing an ester of C | 11-07-2013 |
| 20130303615 | ANTIMICROBIAL COMPOSITIONS AND METHODS - Antimicrobial compositions, especially those useful when applied topically, particularly to mucosal tissues (i.e., mucous membranes), including, in particular, an antimicrobial lipid component, such as a fatty acid ester, fatty ether, or alkoxide derivative thereof. The compositions can also include an enhancer component, a surfactant, a hydrophobic component, and/or a hydrophilic component. Such compositions provide effective topical antimicrobial activity and are accordingly useful in the treatment and/or prevention of conditions that are caused, or aggravated by, microorganisms (including viruses). | 11-14-2013 |
| 20140005265 | METHODS FOR TREATING HYPERTRIGLYCERIDEMIA | 01-02-2014 |
| 20140094517 | PRESERVATIVE SYSTEM FOR COSMETIC FORMULATIONS- COMPOSITIONS AND METHODS THEREOF - The present invention relates to preservation of cosmetic formulations. More specifically, the present invention relates to a preservative composition for cosmetic formulations comprising thymol, monolaurin and magnolol obtained from supercritical fluid extracts of | 04-03-2014 |
| 20140100276 | EMULSIFIED COMPOSITION - The emulsion composition of the present invention contains
| 04-10-2014 |
| 20140155482 | FLUID COMPOSITIONS THAT CAN FORM A COATING HAVING ANTIVIRAL PROPERTIES - The aim of the present invention is to provide a fluid composition that can form a coating, said composition being characterized in that it contains, at least in a solvent medium, an effective amount of at least one natural virucide selected from among lauric acid, monolaurin, lactoferrin and essential oils having antiviral activity and/or one of the precursors thereof, said composition having a viscosity of 30 mPa·s to 40 Pa·s at room temperature and pressure. | 06-05-2014 |
| 20140323572 | Antimicrobial Mixture of Aldehydes, Organic Acids and Fatty Acid Esters - An antimicrobial composition and method for extending the shelf-life of water, food/feed or food/feed ingredients, comprising: 5-25 wt. % nonanoic acid, 1-25 wt. % organic acid ester, 1-50 wt. % of a single or mixture of C | 10-30-2014 |
| 20140371313 | Cyclohexane-1,3-Diones for Use in the Treatment of Amyotrophic Lateral Sclerosis - The present invention relates to the identification of provided cyclohexane-1,3-diones (CHD compounds) and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The invention also provides methods of preparing the provided CHD compounds. | 12-18-2014 |
| 20150094368 | METHODS OF REDUCING MICROBIAL CONTAMINATION - Methods of delaying the onset of an infection or preventing an infection caused by a microbial organism in an internal cavity of a subject are provided. Methods of killing or inactivating microorganisms in at least a portion of the urethra of a subject are provided. | 04-02-2015 |
| 20150290099 | NOVEL PSEUDOCERAMIDE COMPOUND AND PRODUCTION METHOD FOR SAME - The present invention provides: a novel pseudoceramide compound, an isomer thereof, a pharmaceutically acceptable salt thereof, a prodrug thereof, a hydrate thereof or a solvate thereof. The present invention has a skin protecting effect in that the invention has a superior effect in skin moisturisation and is outstandingly stable and soluble, and thus the invention can protect the skin from external irritation without side effects, and can be used as an active substance in damaged skin recovery and prevention. Consequently, the invention can be used as a skin-moisturising dermatological external composition, cosmetic composition or pharmaceutical composition. | 10-15-2015 |
| 20150290114 | WATER-IN-OIL EMULSION COMPOSITION - To provide a water-in-oil emulsion composition having a high stability and which provides fresh feeling in use and glossy finish. The water-in-oil emulsion composition of the present invention is characterized by comprising: (a) 1 to 20 mass % of a polyhydric alcohol fatty acid ester and/or a hydrocarbon; (b) 3 to 20 mass % of a transparent non-volatile silicone oil that separates when mixed with component (a) at 25° C.; (c) 0.1 to 5 mass % of zinc decyl trisiloxanecarboxylate; and (d) water. | 10-15-2015 |
| 20150305998 | COSMETIC COMPOSITIONS FOR HYDRATING SKIN - A cosmetic composition suitable for topical application is provided. The cosmetic composition comprises: a safe and effective amount of a humectant; a safe and effective amount of a lipid bilayer structurant, and a safe and effective amount of a chaotropic agent. The chaotropic agent denatures the cross-linked proteinaceous layer sitting immediately above skin thereby increasing the amount of humectant and lipid bilayer structurant that enters the stratum corneum; the humectant binds together with water molecules and the lipid bilayer structurant knits together the lipid bilayers of the stratum corneum thereby preventing water loss. | 10-29-2015 |
| 20150342179 | COMPOSITIONS FOR INTERNAL AND EXTERNAL USE AS AN INSECTICIDE, OVICIDE, REPELLENT AND FOR WOUND HEALING - Exemplary embodiments of the present invention relate to pesticides, insecticides, insect repellant, insect anti-feeding, cleaning, glue dissolving and anti-irritation and wound healing compositions for humans and animals and, more particularly, to such compositions which are effective in killing, removing and/or repelling a wide range of endoparasites, ectoparasites and insects while also being non-toxic to humans, animals, and the environment. An exemplary embodiment of the present invention is directed to an aqueous composition including a mixture of at least one ethanolamide and at least one esterified fatty acid. Another exemplary embodiment of the present invention is directed to an aqueous composition including at least one esterified fatty acid in water and at least one emulsifier. The aqueous compositions may be used as a cleaning composition, insecticide, insect repellant, glue solvent or to relieve irritation from and/or promote healing of insect bites, skin abrasions superficial burns and wounds. | 12-03-2015 |
| 20160015612 | Preservative System for Cosmetic Formulations-Compositions and Methods Thereof - The present invention relates to preservation of cosmetic formulations. More specifically, the present invention relates to a preservative composition for cosmetic formulations comprising thymol, monolaurin and magnolol obtained from supercritical fluid extracts of | 01-21-2016 |
| 20160022567 | WAXES HAVING OIL-IN-WATER SELF-EMULSIFYING AND WATER GEL-FORMING PROPERTIES, COMPOSITIONS, USES AND METHODS RELATING TO SAME - The present invention relates to waxes useful for cosmetic applications having stable oil-in-water emulsion-forming properties and, in some embodiments, stable gel-in-water-forming properties. In some embodiments, the waxes exhibit self-emulsifying properties, and can be produced without the addition of any other substances to achieve the emulsion (e.g., co-emulsifiers, hydrophilic polymers, polar surfactants, rheological modifiers, gelling agents). The waxes generally comprise: (a) polyglyceryl fatty acid ester, (b) a glycerol fatty acid ester, and 9c) a fatty alcohol. In particular embodiments, the polyglyceryl fatty acid ester can be a polyglyceryl-2, -3, or -4 fatty acid ester, and the fatty chain lengths of (a)-(c) can range from C12 to C22. In more particular embodiments, the waxes can comprise polyglyceryl stearate, glyceryl stearate, and stearyl alcohol. Gels, oil-in-water emulsions, and other compositions produced from the waxes, as well as uses and methods relating thereto, are also disclosed. | 01-28-2016 |
| 20160175244 | COMPOSITIONS FOR TOPICAL TREATMENT OF MICROBIAL INFECTIONS | 06-23-2016 |
| 20160249614 | CONTINUOUS ON-LINE ADJUSTABLE DISINFECTANT/SANITIZER/BLEACH GENERATOR | 09-01-2016 |
| 20170231885 | Body Sculpting | 08-17-2017 |
| 20190141999 | Methods For Repelling Blood-Sucking And Biting Insects, Ticks And Mites | 05-16-2019 |
